These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3229307)

  • 1. [The mechanism of action of Shiga toxin].
    Dubinina EN; Luk'ianov EV; Kozlov IuV; Baev AA
    Dokl Akad Nauk SSSR; 1988; 302(1):226-8. PubMed ID: 3229307
    [No Abstract]   [Full Text] [Related]  

  • 2. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.
    Endo Y; Tsurugi K; Yutsudo T; Takeda Y; Ogasawara T; Igarashi K
    Eur J Biochem; 1988 Jan; 171(1-2):45-50. PubMed ID: 3276522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of ribosome binding by the Shiga toxin A1 subunit, using competition and site-directed mutagenesis.
    Skinner LM; Jackson MP
    J Bacteriol; 1997 Feb; 179(4):1368-74. PubMed ID: 9023224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga toxin attacks bacterial ribosomes as effectively as eucaryotic ribosomes.
    Suh JK; Hovde CJ; Robertus JD
    Biochemistry; 1998 Jun; 37(26):9394-8. PubMed ID: 9649321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Self-inhibiting N-glycosidase activity of shigella toxin].
    Polesskaia AN; Garred O; Olsnes S; Kozlov IuV
    Mol Biol (Mosk); 1997; 31(3):528-35. PubMed ID: 9297098
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of shiga toxin and sonicates of Shigella isolates from children with neurologic manifestation on neuroblastoma cell lines.
    Ashkenazi S; Yuhas Y; Even-Tov S; Kaminsky E; Danon YL
    Isr J Med Sci; 1994 Aug; 30(8):604-10. PubMed ID: 8045741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli).
    Takeda Y; Kurazono H; Yamasaki S
    Microbiol Immunol; 1993; 37(8):591-9. PubMed ID: 8246822
    [No Abstract]   [Full Text] [Related]  

  • 8. Shiga toxin as inhibitor of protein synthesis.
    Donohue-Rolfe A; Jacewicz M; Keusch GT
    Methods Enzymol; 1988; 165():231-5. PubMed ID: 3068485
    [No Abstract]   [Full Text] [Related]  

  • 9. The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit.
    Reisbig R; Olsnes S; Eiklid K
    J Biol Chem; 1981 Aug; 256(16):8739-44. PubMed ID: 6894922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga toxin from Shigella dysenteriae 1 inhibits protein synthesis in reticulocyte lysates by inactivation of aminoacyl-tRNA binding.
    Brown JE; Obrig TG; Ussery MA; Moran TP
    Microb Pathog; 1986 Aug; 1(4):325-34. PubMed ID: 3334156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants.
    Garred O; Dubinina E; Holm PK; Olsnes S; van Deurs B; Kozlov JV; Sandvig K
    Exp Cell Res; 1995 May; 218(1):39-49. PubMed ID: 7737376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shigella toxin inhibition of binding and translation of polyuridylic acid by Escherichia coli ribosomes.
    Olenick JG; Wolfe AD
    J Bacteriol; 1980 Mar; 141(3):1246-50. PubMed ID: 6988411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in the molecular mechanism of action of bacterial toxins, in particular of diphtheria, cholera, coli, botulinum and shigella toxins as well as tetanospasmin and the toxins of staphylococcus aureus].
    Kolb E
    Z Gesamte Inn Med; 1984 Mar; 39(6):85-92. PubMed ID: 6375175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanism of action of ribotoxins].
    Sawasaki T; Endo Y
    Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):355-62. PubMed ID: 11268633
    [No Abstract]   [Full Text] [Related]  

  • 17. RNA present in post-ribosomal supernatants makes ribosomes susceptible to inactivation by gelonin and alpha-sarcin.
    Brigotti M; Carnicelli D; Sperti S; Montanaro L
    Biochem Mol Biol Int; 1994 Mar; 32(3):585-96. PubMed ID: 7518279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
    Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga-like toxin production and attaching effacing activity of Escherichia coli associated with calf diarrhea.
    Mainil JG; Duchesnes CJ; Whipp SC; Marques LR; O'Brien AD; Casey TA; Moon HW
    Am J Vet Res; 1987 May; 48(5):743-8. PubMed ID: 3296889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cell stress response pathways by Shiga toxins.
    Tesh VL
    Cell Microbiol; 2012 Jan; 14(1):1-9. PubMed ID: 21899699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.